Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy
NCT01920984
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Proliferative Diabetic Retinopathy
Interventions
DRUG:
intravitreal injection of 1.25 mg of bevacizumab
Sponsor
National Taiwan University Hospital